Walleye Capital’s Madison Square Garden MSGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$225K Buy
700
+600
+600% +$179K ﹤0.01% 3267
2025
Q4
$25.9K Sell
100
-2,100
-95% -$478K ﹤0.01% 4213
2025
Q3
$499K Buy
+2,200
New +$451K ﹤0.01% 2606
2025
Q1
Sell
-800
Closed -$181K 4801
2024
Q4
$181K Sell
800
-10,400
-93% -$2.32M ﹤0.01% 3835
2024
Q3
$2.33M Sell
11,200
-11,400
-50% -$2.29M ﹤0.01% 1796
2024
Q2
$4.25M Buy
22,600
+21,900
+3,129% +$4.06M 0.01% 1411
2024
Q1
$129K Sell
700
-16,000
-96% -$2.97M ﹤0.01% 4243
2023
Q4
$3.04M Sell
16,700
-2,400
-13% -$416K 0.01% 1469
2023
Q3
$3.37M Buy
19,100
+8,700
+84% +$1.64M 0.01% 1330
2023
Q2
$1.96M Buy
10,400
+9,900
+1,980% +$1.87M 0.01% 1351
2023
Q1
$97.4K Buy
+500
New +$93.1K ﹤0.01% 2942

Other funds holding MSGS

Walleye Capital's MSGS Position: Q1 2026 in Review

Walleye Capital reduced its Madison Square Garden (MSGS) stake by 2% in Q1 2026, selling an estimated $700K and leaving 113,285 shares worth $36.4M. The position accounts for 0.15% of the portfolio, ranked #71.

Walleye Capital first reported a position in MSGS in Q3 2018 and has held it in 13 quarters since. 408 funds tracked by Wall St. Rank hold MSGS as of Q1 2026.

  • Walleye Capital held 113,285 shares of Madison Square Garden worth $36.4M as of Q1 2026.
  • Walleye Capital sold 2,348 Madison Square Garden shares in Q1 2026, an estimated $700K.
  • Madison Square Garden made up 0.15% of Walleye Capital's portfolio in Q1 2026, its #71 holding.
  • Walleye Capital first reported a position in Madison Square Garden in Q3 2018 and has held it in 13 quarters since.
  • 408 funds tracked by Wall St. Rank held Madison Square Garden as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.